Abstract
Objectives
Lymph node metastasis (LNM) in colorectal cancer (CRC) patients is not only associated with the tumor’s local pathological characteristics but also with systemic factors. This study aims to assess the feasibility of using body composition and pathological features to predict LNM in early stage colorectal cancer (eCRC) patients.
Methods
A total of 192 patients with T1 CRC who underwent CT scans and surgical resection were retrospectively included in the study. The cross-sectional areas of skeletal muscle, subcutaneous fat, and visceral fat at the L3 vertebral body level in CT scans were measured using Image J software. Logistic regression analysis were conducted to identify the risk factors for LNM. The predictive accuracy and discriminative ability of the indicators were evaluated using receiver operating characteristic (ROC) curves. Delong test was applied to compare area under different ROC curves.
Results
LNM was observed in 32 out of 192 (16.7%) patients with eCRC. Multivariate analysis revealed that the ratio of skeletal muscle area to visceral fat area (SMA/VFA) (OR = 0.021, p = 0.007) and pathological indicators of vascular invasion (OR = 4.074, p = 0.020) were independent risk factors for LNM in eCRC patients. The AUROC for SMA/VFA was determined to be 0.740 (p < 0.001), while for vascular invasion, it was 0.641 (p = 0.012). Integrating both factors into a proposed predictive model resulted in an AUROC of 0.789 (p < 0.001), indicating a substantial improvement in predictive performance compared to relying on a single pathological indicator.
Conclusion
The combination of the SMA/VFA ratio and vascular invasion provides better prediction of LNM in eCRC.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Colorectal cancer is a prevalent gastrointestinal malignancy with an annual global incidence of approximately 1.8 million individuals. The implementation of a population-based screening programs for CRC has led to an increased detection rate of early stage (T1) CRC (eCRC) [1,2,3]. The treatment and prognosis of eCRC primarily depend on the presence or absence of lymph node metastasis (LNM) at the time of diagnosis [4, 5]. Most eCRC can be effectively treated with endoscopic submucosal dissection (ESD) [6, 7]. However, in cases where the pathological evaluation reveals high-risk indicators for LNM, such as submucosal infiltration depth (≥ 1000 μm), vascular invasion, or poorly differentiated histology, additional surgical treatment may be necessary [8,9,10].
According to research, only 8–16% of patients with eCRC who undergo surgical resection actually have LNM [11,12,13,14]. This suggests that approximately 80% of eCRC patients may potentially be subjected to unnecessary surgical intervention. Accurate predicting of LNM prior to ESD or surgical procedures is challenging. Consequently, it is a common practice among medical professionals to favor less invasive endoscopic interventions, even in situations where surgical intervention is actually necessary. However, this approach carries drawbacks for both patients and medical professionals. The precise preoperative detection of LNM in eCRC patients is important in prognostic assessment and guiding for reasonable therapeutic strategies. Therefore, it is imperative to identify an accurate marker for early prediction of LNM prior to treatment.
Currently, the focus of determining lymph node metastasis in eCRC lies primarily on the tumor itself, considering factors such as the depth of tumor infiltration and tumor differentiation. However, the significance of important nutritional and immune status, both at the whole body and local tumor level, is often overlooked. This oversight contributes to the limited predictive accuracy of existing methods. Previous research has established a correlation between elevated neutrophil-to-lymphocyte ratio (NLR) and other inflammatory marker abnormalities with sarcopenia, as well as their potential as prognostic indicators [15]. Furthermore, prior studies have illustrated the ability of inflamed adipose tissue to facilitate LNM in eCRC and serve as a marker for the overall immune status in CRC patients [15,16,17,18,19,20]. The objective of this study was to assess the association between skeletal muscle and adipose tissue status, as determined through clinical methods, and LNM in patients diagnosed with T1 CRC.
Contrast-enhanced computed tomography (CT) is suggested by the National Comprehensive Cancer Network guidelines as recommended preoperative evaluations for CRC [4]. However, the accuracy of using CT to identify positive lymph nodes for determining N staging is poor, with diagnostic accuracy ranging from 59 to 68% [21, 22]. Additionally, this method heavily depends on the subjective interpretation of doctors. With consideration of such limitations, we conducted a study to investigate the feasibility of using CT images to precisely assess lymph node status.
Consequently, the present study aimed to investigate the potential of CT measurement of skeletal muscle and adipose tissue areas for the accurate evaluation of lymph node status in eCRC.
Methods
Patients
This single-center retrospective study received study-specific institutional review board approval. This study followed STROBE reporting guidelines (see S1 STROBE Checklist). Between June 2018 and March 2023, 259 consecutive eligible patients with primary colorectal cancer in Nanjing Drum Tower Hospital were selected. The inclusion criteria were as follows: [a] confirmed by histopathology as T1 stage colorectal adenocarcinoma; [b] underwent curative surgery (R0) and lymph node dissection; and [c] underwent a CT scan carried out less than 2 weeks before the surgery. The exclusion criteria were as follows: [a] imaging examination shows obvious enlarged lymph nodes; [b] pathological tumor stage Tis, T2, T3, or T4; [c] distant metastasis; [d] two or more primary tumors; [e] accepted preoperative treatment; and [f] a previous history of malignant disease. A total of 192 patients were included in the study (Fig. 1). The patients were categorized into two groups: LNM-positive and LNM-negative groups, based on the presence or absence of pathological confirmed LNM.
Clinical and pathological characteristics
Retrieve clinical information such as gender, age, body mass index (BMI), carcinoembryonic antigen (CEA), CA199, white blood cell (WBC), glucose (GLU), urea nitrogen, creatinine, cholesterol, apolipoprotein A, apolipoprotein B and C-reactive protein(CRP) from electronic medical record systems. The postoperative pathological results, including tumor site, histological grade, depth of tumor infiltration, degree of vascular invasion, and tumor budding, were all reviewed by senior pathologists. All specimens were staged according to the 8th edition of the American Joint Commission on Cancer (AJCC) TNM staging system.
Image acquisition and analysis
All patients underwent abdominal CT examination in our institution within 2 weeks before surgery. Image J (version 1.53t) software was adopted for the measurement of the cross-sectional areas of skeletal muscle, subcutaneous fat, and visceral fat at the L3 vertebral body level in CT scans. An illustration is shown in Fig. 2, where the dark blue segment represents muscle tissue, the purple segment represents subcutaneous adipose tissue, and the light blue segment represents visceral adipose tissue. Additionally, the ratio of skeletal muscle to visceral fat area (SMA/VFA) was also calculated.
Statistical analysis
Statistical analysis was conducted using SPSS (version 26.0). Continuous variables were presented as mean ± standard deviation (SD). Independent sample t-tests or Mann–Whitney U-tests were used to test the differences between continuous variables. Categorical variables were analyzed using Pearson’s chi-square (χ2) test, with appropriate continuity correction. Significant variables with a significance level (p < 0.1) in the univariate analysis related to LNM were further adjusted in the multivariate analysis using a logistic regression model. The multivariate logistic regression analysis was conducted to screen the independent risk factors for LNM. Utilizing logistic regression analysis to amalgamate various indicators into a novel predictive measure, considering the resultant value as a combined indicator. We used R packages “caret” and “stats” to perform k-fold cross-validation with k = 5 folds to evaluate the model performance. The diagnostic accuracy of LNM was evaluated by calculating the area under the receiver operating characteristics curve (AUROC) based on the selected factors. To compare the performance of different ROC curves, the Delong test was used. p values < 0.05 (two-sided) were considered statistical significance.
Results
Patients’ baseline characteristics
A total of 192 eligible patients were recruited for our study, with the majority being elderly individuals, having an average age of 60.4 years. More than half of the patients (54.8%) were male. The patients were divided into two groups based on LNM positivity, with a LNM positivity rate of 16.7%. There were no significant differences observed between the LNM-positive and LNM-negative groups in terms of age, gender, CEA, CA199, WBC, ALB, GLU, CRP, etc. (Table 1).
We conducted an analysis of postoperative pathological conditions in two patient groups and observed no statistically significant differences in tumor location, tumor type, tumor size, and tumor budding between the groups. However, we did find that the proportion of grade 3 tumor budding in the LNM-positive group was higher than that in the negative group. This difference, though not statistically significant, may be attributed to the small sample size. Tumor cell differentiation serves as an indicator of tumor malignancy, with poorly differentiated cells being more invasive. Our study revealed a significantly higher proportion of poorly differentiated patients in the LNM-positive group compared to the negative group. Vascular invasion has long been recognized as a risk factor for LNM, and our study further confirmed a higher incidence of vascular invasion in the LNM group.
Muscle and fat characteristics
To examine the impact of skeletal muscle and fat on cancer cell behavior, we initially assessed the differences in blood indicators reflecting skeletal muscle and fat metabolism between the LNM-positive and LNM-negative groups (Table 2). The blood levels of creatinine and urea nitrogen, which indirectly indicate skeletal muscle levels, were significantly lower in the LNM-positive group. Interestingly, we did not observe any significant differences in blood indicators related to fat metabolism, such as cholesterol, apolipoprotein A, and apolipoprotein B, between the two groups.
We assessed the skeletal muscle and fat status of patients by directly measuring the skeletal muscle and fat area at the L3 level using CT images. We were able to differentiate between visceral fat and subcutaneous fat. Our findings revealed that the SMA in the LNM-positive group showed a decrease, although it was not statistically significant (134.1 ± 30.4 vs. 122.7 ± 30.5, p = 0.055). Interestingly, the content of VFA significantly increased in the LNM-positive group (88.1 ± 48.1 vs. 110.1 ± 31.4, p = 0.014), while there was no significant difference in SFA (133.4 ± 40.3 vs. 134.5 ± 24.3, p = 0.882). Combining the SMA with the VFA, we discovered that the ratio of these two indicators exhibited a more significant change between the LNM-positive and LNM-negative groups (2.0 ± 1.3 vs. 1.2 ± 0.4, p < 0.001) (Fig. 3).
Multivariate analysis
Clinical factors were included in the logistic regression analysis, and those with a p-value less than 0.1 were included in the multivariate analysis. The results revealed that the SMA/VFA ratio (OR: 0.021, p = 0.007) and vascular invasion (OR: 4.074, p = 0.020) were identified as independent risk factors for lymph node metastasis. Tumor budding is commonly recognized as a risk factor for lymph node metastasis. Our multivariate analysis demonstrated that grade 3 tumor budding had an odds ratio of 6.373 (95% CI: 0.849–47.863), but the difference was not statistically significant (p = 0.072) (Table 3).
Comparison of the predictive accuracy between independent prognostic factor
The classic pathological indicator of vascular invasion was first calculated, resulting in an AUROC of 0.641 (95%: 0.524–0.757, p = 0.012), indicating weak predictive power (Table 4, Fig. 4). Additionally, it has been observed that some doctors tend to make more aggressive judgments, leading to an increased false-positive rate and unnecessary surgeries for patients. However, the AUROC of SMA/VFA is 0.74 (95%: 0.668–0.826, p < 0.001), demonstrating a slight improvement in its predictive performance compared to pathological indicators. To further enhance the predictive model, we used binary logistic regression to predict SMA/VFA and vascular invasion as a new indicator called “Combined,” and observed that this indicator has a higher AUROC for LNM. Furthermore, employing fivefold cross-validation as a method of internal data validation to assess overfitting in the logical model yielded accuracies of 0.92, 0.87, 0.87, 0.82, and 0.84. These findings suggest that the model effectively captures patterns and similarities within unseen data. Remarkably, the AUROC of this model was found to be 0.789 (95%: 0.706–0.871, p < 0.001), and when compared to a single pathological indicator through DeLong test, the ROC was significantly better (p < 0.001). Therefore, by evaluating the content of skeletal muscle and visceral fat through CT scans, we can improve the ability to predict the presence of LNM using pathological methods.
Discussion
This study explored the value of CT for the preoperative prediction of LNM in early-stage CRC. We utilized CT to measure the area of L3 plane visceral fat and skeletal muscle in eCRC patients to infer the lymph node metastasis status. Our results show that within our relatively small series, LNM status can be predicted with a good performance.
There exists substantial evidence substantiating the correlation between visceral obesity and the incidence and advancement of diverse tumors, notably colorectal cancer [23,24,25]. However, the linkage between visceral obesity and lymph node metastasis has only recently garnered attention in scholarly investigations. The release of inflammatory factors, such as TNF-a, IL-6, and MCP1, by the visceral fat of obese individuals induces localized chronic inflammation, thereby establishing a microenvironment that fosters tumor progression [26,27,28,29]. In this environment, tumor proliferation activity is activated, exhibiting more invasiveness, and the chances of tumor metastasis to lymph nodes increase [29, 30]. Brockmoeller et al. analyzed H&E slices of primary CRC through deep learning to identify inflamed fat, which can predict the status of lymph node metastasis in eCRC [18]. Due to the limitation of obtaining pathological results only after surgery, our study aims to investigate the feasibility of utilizing CT scans to evaluate the visceral fat status of patients prior to surgery and its potential in predicting the occurrence of LNM. Through our comprehensive analysis of the CT L3 level, it has been observed that LNM-positive patients exhibit a significantly larger visceral fat area, averaging 110, in contrast to LNM-negative patients who possess a relatively smaller visceral fat area of 88. However there is no significant correlation between SFA and LNM status, suggesting that visceral fat promotes tumor metastasis in the local microenvironment. This finding also highlights the limitations of using BMI as an indicator.
Sarcopenia are frequently observed in CRC patients and was associated with poor prognosis [31,32,33,34]. Previous studies have identified a noteworthy correlation between SMI and the infiltration of CD8 + cells within CRC tumors. Patients with high SMI exhibit a greater abundance of CD8 + T cells infiltrating the tumor in comparison to those with low SMI [20, 35]. Richards et al. found a clear correlation between muscle reduction in CRC patients and systemic inflammatory response [36]. Based on these findings, we can postulate that the condition of skeletal muscles might serve as an indicator of an individual’s immune response against tumor growth, consequently influencing the occurrence of lymph node metastasis in eCRC patients. In our thorough investigation, we assessed the skeletal muscle status by analyzing the skeletal muscle area in the L3 slice of CT scans. Intriguingly, our results revealed that the skeletal muscle area was notably smaller in CRC cases with positive LNM compared to those displaying negative LNM.
In our study, we investigated the association between skeletal muscle and visceral fat in predicting lymph node metastasis (LNM) in early colorectal cancer (eCRC). Previous research has introduced the concept of sarcopenic obesity (SOB), which refers to a decrease in skeletal muscle mass and strength accompanied by an increase in body fat [37,38,39]. However, SOB does not distinguish between subcutaneous fat and visceral fat. Our findings demonstrate that subcutaneous fat content is not correlated with LNM in eCRC. Considering that patients with positive lymph nodes have a smaller skeletal muscle area and a larger visceral fat area, we utilized a ratio to establish a connection between the two factors. Our results indicate that this ratio has a better predictive effect on lymph node metastasis compared to considering skeletal muscle or visceral fat alone.
The limitations of our study include a single-center setting, a small sample size, and the use of CT evaluation methods that may not be as precise. This is mainly due to the relatively low number of patients with T1 stage colorectal cancer, particularly those who have undergone surgery. While MRI is generally considered more effective in assessing muscle and fat in patients, it is not commonly performed on eCRC patients. In future research, we aim to enhance the CT evaluation method for skeletal muscle and visceral fat and develop machine learning models to improve the accuracy of predictions.
Conclusion
The integration of the SMA/VFA ratio alongside vascular invasion yields enhanced prognostication of LNM in eCRC. Should our findings be corroborated by further investigations, the inclusion of skeletal muscle area and visceral fat area measurements in routine imaging reports, in conjunction with pathological indicators, holds significant promise for the prediction of lymph node metastasis.
Data availability
The data supporting the results of this study can be reasonably requested by the corresponding author Ding Chao.
References
Bretthauer M et al (2016) Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial. JAMA Intern Med 176(7):894–902. https://doi.org/10.1001/jamainternmed.2016.0960
Siegel RL et al (2023) Colorectal cancer statistics, 2023. CA Cancer J Clin 73(3):233–254. https://doi.org/10.3322/caac.21772
Fields AC et al (2021) Lymph node positivity in T1/T2 rectal cancer: a word of caution in an era of increased incidence and changing biology for rectal cancer. J Gastrointestinal Surg: Official J Soc Surg Alimentary Tract 25(4):1029–1035. https://doi.org/10.1007/s11605-020-04580-z
Benson AB et al (2021) Colon cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19(3):329–359. https://doi.org/10.6004/jnccn.2021.0012
Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660
Spadaccini M et al (2022) Clinical outcome of non-curative endoscopic submucosal dissection for early colorectal cancer. Gut. https://doi.org/10.1136/gutjnl-2020-323897
Overwater A et al (2018) Endoscopic resection of high-risk T1 colorectal carcinoma prior to surgical resection has no adverse effect on long-term outcomes. Gut 67(2):284–290. https://doi.org/10.1136/gutjnl-2015-310961
Hashiguchi Y et al (2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25(1):1–42. https://doi.org/10.1007/s10147-019-01485-z
Cervantes A et al (2023) Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 34(1):10–32. https://doi.org/10.1016/j.annonc.2022.10.003
Ichimasa K et al (2022) Current problems and perspectives of pathological risk factors for lymph node metastasis in T1 colorectal cancer: systematic review. Dig Endosc 34(5):901–912. https://doi.org/10.1111/den.14220
Kandimalla R et al (2019) Gene expression signature in surgical tissues and endoscopic biopsies identifies high-risk T1 colorectal cancers. Gastroenterology 156(8):2338–41.e3. https://doi.org/10.1053/j.gastro.2019.02.027
Backes Y et al (2019) Multicentre prospective evaluation of real-time optical diagnosis of T1 colorectal cancer in large non-pedunculated colorectal polyps using narrow band imaging (the OPTICAL study). Gut 68(2):271–279. https://doi.org/10.1136/gutjnl-2017-314723
Yasue C et al (2019) Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions. J Gastroenterol 54(8):708–717. https://doi.org/10.1007/s00535-019-01564-y
Kessels K et al (2019) Pedunculated morphology of T1 colorectal tumors associates with reduced risk of adverse outcome. Clin Gastroenterol Hepatol 17(6):1112–20.e1. https://doi.org/10.1016/j.cgh.2018.08.041
Feliciano EMC et al (2017) Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study. JAMA Oncol 3(12):e172319. https://doi.org/10.1001/jamaoncol.2017.2319
Charette N et al (2019) Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials. BMC Cancer 19(1):134. https://doi.org/10.1186/s12885-019-5319-8
Daitoku N et al (2022) Preoperative skeletal muscle status is associated with tumor-infiltrating lymphocytes and prognosis in patients with colorectal cancer. Ann Gastroenterol Surg 6(5):658–6661. https://doi.org/10.1002/ags3.12570
Brockmoeller S et al (2021) Deep learning identifies inflamed fat as a risk factor for lymph node metastasis in early colorectal cancer. J Pathol 256(3):269–281. https://doi.org/10.1002/path.5831
Cao Y et al (2021) Development of a nomogram combining clinical risk factors and dual-energy spectral CT parameters for the preoperative prediction of lymph node metastasis in patients with colorectal cancer. Front Oncol 11:689176. https://doi.org/10.3389/fonc.2021.689176
Daitoku N et al (2022) Preoperative skeletal muscle status is associated with tumor-infiltrating lymphocytes and prognosis in patients with colorectal cancer. Ann Gastroenterol Surg 6(5):658–666. https://doi.org/10.1002/ags3.12570
Filippone A et al (2004) Preoperative T and N staging of colorectal cancer: accuracy of contrast-enhanced multi-detector row CT colonography–initial experience. Radiology 231(1):83–90. https://doi.org/10.1148/radiol.2311021152
Hundt W, Braunschweig R, Reiser M (1999) Evaluation of spiral CT in staging of colon and rectum carcinoma. Eur Radiol 9(1):78–84. https://doi.org/10.1007/s003300050632
Bardou M, Barkun AN, Martel M (2013) Obesity and colorectal cancer. Gut 62(6):933–947. https://doi.org/10.1136/gutjnl-2013-304701
Bardou M et al (2022) Review article: Obesity and colorectal cancer. Aliment Pharmacol Ther 56(3):407–418. https://doi.org/10.1111/apt.17045
Pedrazzani C et al (2020) Impact of visceral obesity and sarcobesity on surgical outcomes and recovery after laparoscopic resection for colorectal cancer. Clin Nutr 39(12):3763–3770. https://doi.org/10.1016/j.clnu.2020.04.004
Gonzalez MC et al (2014) Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr 99(5):999–1005. https://doi.org/10.3945/ajcn.113.071399
Quail DF, Dannenberg AJ (2019) The obese adipose tissue microenvironment in cancer development and progression. Nat Rev Endocrinol 15(3):139–154. https://doi.org/10.1038/s41574-018-0126-x
Di Franco S et al (2021) Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery. Nat Commun 12(1):5006. https://doi.org/10.1038/s41467-021-25333-9
Di Franco S et al (2021) Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery. Nat Commun 12(1):5006. https://doi.org/10.1038/s41467-021-25333-9
Theriau CF et al (2017) Proliferative endocrine effects of adipose tissue from obese animals on MCF7 cells are ameliorated by resveratrol supplementation. PloS One 12(9):e0183897. https://doi.org/10.1371/journal.pone.0183897
Vergara-Fernandez O, Trejo-Avila M, Salgado-Nesme N (2020) Sarcopenia in patients with colorectal cancer: a comprehensive review. World J Clin Cases 8(7):1188–1202. https://doi.org/10.12998/wjcc.v8.i7.1188
Ruan GT et al (2023) Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia. J Cachexia Sarcopenia Muscle 14(6):2813–2823. https://doi.org/10.1002/jcsm.13358
Nakanishi R et al (2018) Sarcopenia is an independent predictor of complications after colorectal cancer surgery. Surg Today 48(2):151–157. https://doi.org/10.1007/s00595-017-1564-0
Baracos VE, Arribas L (2018) Sarcopenic obesity: Hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol 29(suppl_2):ii1–ii9. https://doi.org/10.1093/annonc/mdx810
Anoveros-Barrera A et al (2019) Immunohistochemical phenotyping of T cells, granulocytes, and phagocytes in the muscle of cancer patients: association with radiologically defined muscle mass and gene expression. Skelet Muscle 9(1):24. https://doi.org/10.1186/s13395-019-0209-y
Richards CH et al (2012) The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PloS One 7(8):e41883. https://doi.org/10.1371/journal.pone.0041883
Choi KM (2016) Sarcopenia and sarcopenic obesity. Korean J Intern Med 31(6):1054–1060. https://doi.org/10.3904/kjim.2016.193
Batsis JA, Villareal DT (2018) Sarcopenic obesity in older adults: Aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol 14(9):513–537. https://doi.org/10.1038/s41574-018-0062-9
Gortan Cappellari G et al (2022) Sarcopenic obesity: what about in the cancer setting? Nutrition 98:111624. https://doi.org/10.1016/j.nut.2022.111624
Funding
This research was funded by the National Natural Science Foundation of China (82172149), the CIMF-CSPEN Project (Z-2017–24-2211), and funding for Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (2022-LCYJ-PY-17 and 2023-LCYJ-MS-02).
Author information
Authors and Affiliations
Contributions
Shizhen Zhou and Qinggang Yuan conceived and designed the study, analyzed the data, and drafted the manuscript. Lixiang Liu and Kai Wang collected the data. Ji Miao and Hao Wang revised it critically for important intellectual content. Wenxian Guan and Chao Ding revised the manuscript. All authors reviewed the manuscript.
Corresponding authors
Ethics declarations
Ethics approval
This retrospective study conducted at a single-center received approval from the Review Committee of Nanjing Drum Tower Hospital, with a waiver granted for documented informed consent.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhou, S., Yuan, Q., Liu, L. et al. Prediction of lymph node metastasis in T1 colorectal cancer based on combination of body composition and vascular invasion. Int J Colorectal Dis 39, 84 (2024). https://doi.org/10.1007/s00384-024-04653-4
Accepted:
Published:
DOI: https://doi.org/10.1007/s00384-024-04653-4